Optimize First-line Treatment for AL Amyloidosis With t (11; 14)
Optimize First-line Treatment for AL Amyloidosis With t (11; 14)
Recruiting · NCT06192979 · Registry updated 2026-07-07Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Optimize First-line Treatment for AL Amyloidosis With t (11; 14) | Immunoglobulin Light-chain Amyloidosis, Neoplasms by Histologic Type, Nutritional and Metabolic Diseases, amyloidosis, immune system disorder, immunoproliferative disorder, lymphoproliferative syndrome, metabolic disease, monoclonal gammopathy, neoplasm, plasma cell neoplasm, proteostasis deficiencies | Recruiting | Not applicable | 2026-07-07 | NCT06192979 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Jin Lu, MD | 2 |
7 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Beijing Anzhen Hospital | Beijing | China | 2 |
| Capital Medical University Affiliated Fuxing Hospital | Beijing | China | 1 |
| Chinese PLA Eastern Theater General Hospital | Nanjing | China | 1 |
| Peking University People's Hospital | Beijing | China | 146 |
| Qilu Hospital of Shandong University (QingDao) | Qingdao | China | 2 |
| Qingdao Municipal Hospital | Qingdao | China | 10 |
| The First Affiliated Hospital of Xi'an Jiao Tong University | Xi’an | China | 9 |